The landscape of diabetic kidney disease transformed

Nat Rev Nephrol. 2020 Feb;16(2):67-68. doi: 10.1038/s41581-019-0240-6.

Author

Katherine R Tuttle^{1

2}

Affiliations

¹ Nephrology Division, Kidney Research Institute and Institute of Translational Health Sciences at the University of Washington, Seattle, WA, USA. katherine.tuttle@providence.org.
² Providence Medical Research Center, Providence Health Care, Spokane, WA, USA. katherine.tuttle@providence.org.

PMID: 31831876
DOI: 10.1038/s41581-019-0240-6

No abstract available

Publication types

Review

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Nephropathies / drug therapy*
Diabetic Nephropathies / metabolism
Disease Progression
Endothelin A Receptor Antagonists / therapeutic use*
Humans
Incretins / therapeutic use*
Kidney Failure, Chronic / metabolism
Kidney Failure, Chronic / prevention & control*
Renal Insufficiency, Chronic / drug therapy*
Renal Insufficiency, Chronic / metabolism
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*

Substances

Endothelin A Receptor Antagonists
Incretins
Sodium-Glucose Transporter 2 Inhibitors